Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Gains from Investment Securities (2018 - 2025)

X4 Pharmaceuticals' Gains from Investment Securities history spans 8 years, with the latest figure at $205000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 51.85% year-over-year to $205000.0; the TTM value through Dec 2025 reached $161000.0, down 74.8%, while the annual FY2025 figure was $161000.0, 74.8% down from the prior year.
  • Gains from Investment Securities reached $205000.0 in Q4 2025 per XFOR's latest filing, up from $152000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q4 2021 to a low of -$369000.0 in Q2 2025.
  • Average Gains from Investment Securities over 5 years is $122789.5, with a median of $120000.0 recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: tumbled 468.42% in 2022, then skyrocketed 1740.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.6 million in 2021, then crashed by 86.59% to $218000.0 in 2022, then increased by 4.13% to $227000.0 in 2023, then crashed by 40.53% to $135000.0 in 2024, then skyrocketed by 51.85% to $205000.0 in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Gains from Investment Securities are $205000.0 (Q4 2025), $152000.0 (Q3 2025), and -$369000.0 (Q2 2025).